Loading...

The Scientist

» obituary and immunology

Most Recent

image: Coriell Institute CEO Dies

Coriell Institute CEO Dies

By Kerry Grens | January 4, 2018

Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.

0 Comments

image: Neuroscientist and Champion of Glia Research Dies

Neuroscientist and Champion of Glia Research Dies

By Kerry Grens | December 28, 2017

Ben Barres of Stanford University described glia’s roles in ensuring neurons’ proper synapse formation and in responding to brain injury.

2 Comments

image: Those We Lost in 2017

Those We Lost in 2017

By Katarina Zimmer | December 27, 2017

The scientific community bid farewell to a number of luminaries this year. 

0 Comments

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By Lucas Laursen | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.

0 Comments

image: European Research Council Founder, Molecular Biologist Dies

European Research Council Founder, Molecular Biologist Dies

By Catherine Offord | November 20, 2017

Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.

0 Comments

image: Cancer Researcher, Former AACR President Dies

Cancer Researcher, Former AACR President Dies

By Kerry Grens | November 13, 2017

Donald Coffey, a longtime professor at Johns Hopkins University, discovered the nuclear matrix within cells and its role in DNA replication.

0 Comments

A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 

1 Comment

image: Pioneer of Crystallography Dies

Pioneer of Crystallography Dies

By Katarina Zimmer | October 27, 2017

Isabella Karle has passed away at age 95. 

0 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. RNA Injection Restores Hearing in Guinea Pigs
  4. Jim Bridenstine Confirmed to Lead NASA